Explaining heterogeneity in meta-analysis: a comparison of methods.
about
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysisEmergency training for in-hospital-based healthcare providers: effects on clinical practice and patient outcomesAntibiotics and antiseptics for pressure ulcersAntibiotics and antiseptics for surgical wounds healing by secondary intentionOrganisation of health services for preventing and treating pressure ulcersAntibiotics for treating infected burn woundsIntra-articular corticosteroid for knee osteoarthritisNegative pressure wound therapy for treating leg ulcersA 'test and treat' strategy for elevated wound protease activity for healing in venous leg ulcersProtease-modulating matrix treatments for healing venous leg ulcersReconstructive surgery for treating pressure ulcersDietary interventions for maintaining cognitive function in cognitively healthy people in late lifeDietary interventions for prevention of dementia in people with mild cognitive impairmentDietary interventions for maintaining cognitive function in cognitively healthy people in mid lifeVitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid lifeVitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in late lifeVitamin and mineral supplementation for prevention of dementia or delaying cognitive decline in people with mild cognitive impairmentPrimary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgeryFluoride gels for preventing dental caries in children and adolescentsNegative pressure wound therapy for treating surgical wounds healing by secondary intentionPatient and lay carer education for preventing pressure ulceration in at-risk populationsA 'test and treat' strategy for elevated wound protease activity for healing in venous leg ulcersBed rest for pressure ulcer healing in wheelchair usersSubcutaneous or intramuscular methotrexate for rheumatoid arthritisAntibiotics and antiseptics for pressure ulcersAntibiotics and antiseptics for surgical wounds healing by secondary intentionTreatment for superficial infusion thrombophlebitis of the upper extremityIntraoperative fluid irrigation for traumatic woundsNegative pressure wound therapy for treating pressure ulcersAntiseptics for burnsExercise interventions for preventing dementia or delaying cognitive decline in people with mild cognitive impairmentExercise interventions for maintaining cognitive function in cognitively healthy people in mid lifeExercise interventions for maintaining cognitive function in cognitively healthy people in late lifeNegative pressure wound therapy for treating leg ulcersNegative pressure wound therapy for treating pressure ulcersCertolizumab pegol (CDP870) for rheumatoid arthritis in adultsNegative pressure wound therapy for treating surgical wounds healing by secondary intentionPrimary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapyTreatment for superficial infusion thrombophlebitis of the upper extremityMegestrol acetate for treatment of anorexia-cachexia syndrome
P2860
Q24185797-3446CAFA-1772-4B2F-9E72-64E1DF9B2DEEQ24185809-FD09F5AA-D73D-4081-A063-FF370469BA48Q24185929-0E1C6DCE-E8C5-4392-9118-74E6E9F97B50Q24186001-2B0AA79F-B7D2-4451-BBDB-C8F600B66732Q24186063-CA9274DB-11B5-4617-980E-D66EB37F8ED0Q24186213-8F3F4001-1F7B-4018-8700-3123B6756EBAQ24186414-410CA0EE-A46E-42E6-BC4B-172237724381Q24186467-8BB1E092-B8D0-45E8-9865-776F23AC5FF9Q24186471-72F32014-80FD-4804-B0B0-B0B5A411235EQ24186752-008D8979-7964-4158-AAD0-CEDEF9E9728BQ24186810-D9A25248-CF0E-4B3E-8BCE-75E2D5C7700CQ24186820-6D15607E-744C-487F-BCF5-BF19C91AF683Q24186832-E21F9906-D408-4A40-B4B8-0E33DF01AC52Q24186838-1BADBD3E-60E8-44A5-89A5-CFCE47D7EC06Q24186855-16C33F18-E7E8-47D5-AC93-7303A23E892AQ24186867-1449E963-FDD0-4853-BEAC-3684465107ABQ24186872-823734BC-5D9E-4A10-B6D2-9566BDED09C1Q24187077-D338B7E5-D777-4469-8153-AA604393E4C8Q24187181-D5CEEF83-5418-4B92-BAA5-86BF664A3455Q24187280-4E5388FD-D734-4945-89FF-9A3C0BA79071Q24187417-2F5CC71D-186B-4436-A58B-DED7541ED511Q24187444-CA8DC1C8-B76A-40E6-B949-B51A4523C0FEQ24187488-4C1FF903-D274-4B25-9B00-25546BC1DFAEQ24187565-547C8196-EC84-4242-9675-18492EA9DD26Q24187644-A16EA51A-D3BD-4A24-9E57-999B92E36A7AQ24187657-0E388605-FEC2-4B4B-B6C3-F3726394962DQ24187714-91BB865B-F416-4AB8-A021-12C50DF57171Q24187801-D3C1D696-0A47-49DD-B1A7-0DC87C94BF3AQ24187874-B96BDC25-BA13-41B3-8985-2C87E23C0A2BQ24188169-C59421A8-9054-456C-A14D-3E2214E13A64Q24188208-3102C8B2-6203-4908-9001-4DAFC330B2E6Q24188214-BDA2CBDE-0CFF-47B6-93E8-050F3372AC5DQ24188220-DF442024-5C94-44B5-9F9D-F35D968CD9E7Q24193227-BD27DC02-3005-495C-A97D-EC17550702D7Q24193352-A34C8EB8-C187-4504-81E7-7DDEF9C74F70Q24193535-6691232E-1189-48F7-A5DB-AAFF761A7288Q24194198-5A36714C-EB82-4763-831E-CB8141CAA03DQ24194257-5471E284-3011-4BD7-8FEE-4F5641A38C70Q24198860-49464AD3-0C5E-4FC3-944E-E187E422254FQ24198954-10841C63-DBCA-4BB1-B4C5-AC5D39A8FC6A
P2860
Explaining heterogeneity in meta-analysis: a comparison of methods.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Explaining heterogeneity in meta-analysis: a comparison of methods.
@en
Explaining heterogeneity in meta-analysis: a comparison of methods.
@nl
type
label
Explaining heterogeneity in meta-analysis: a comparison of methods.
@en
Explaining heterogeneity in meta-analysis: a comparison of methods.
@nl
prefLabel
Explaining heterogeneity in meta-analysis: a comparison of methods.
@en
Explaining heterogeneity in meta-analysis: a comparison of methods.
@nl
P2860
P1476
Explaining heterogeneity in meta-analysis: a comparison of methods.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V
P407
P577
1999-10-01T00:00:00Z